Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries

Hypertension

Volumn 35, Issue 3, 2000, Pages 717-721

  Van Geel, Peter Paul ^a,c   Pinto, Yigal M ^a   Voors, Adriaan A ^a,b   Buikema, Hendrik ^a   Oosterga, Margreeth ^a   Crijns, Harry J G M ^a   Van Gilst, Wiek H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Angiotensin II; Arteries; Genetics; Polymorphism; Receptors, angiotensin II; Risk factors

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; QUINAPRIL;

ADULT; AGED; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; ESSENTIAL HYPERTENSION; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; INTERNAL MAMMARY ARTERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0034097536     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.35.3.717     Document Type: Article

References (24)

1. Weber KT. Extracellular matrix remodeling in heart failure: a role for the novo angiotensin II generation. Circulation. 1997;96:4065-4082.
2. Cambien F, Poirier O. Lecerf L, Evans A, Cambou J-P, Arveiler D. Luc G, Bard J-M, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992;359:641-644.
3. Schunkert H, Hense H-W. Holmer SR, Stender M, Perz S, Keil U, Lorell BH, Riegger GAJ. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med. 1994;330:1634-1638.
4. Pinto YM, van Gilst WH, Kingma JH, Schunkert H, for the CATS Investigators. The deletion-type allele of the angiotensin converting enzyme is associated with progressive ventricular dilatation after anterior myocardial infarction. J Am Coll Cardiol. 1995;25: 1622-1626.
5. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86:1343-1346.
6. Danser AHJ, Schalekamp MADH, Bax WA, van den Brink AM, Saxena PR, Riegger GAJ, Schunkert H. Angiotensin-converting enzyme in the human heart: effect of the deletion/insertion polymorphism. Circulation. 1995;92:1387-1388.
7. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel J-M, Corvol P. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71:169-180.
8. Katsuya T, Koike G, Yee TW, Sharpe N, Jackson R, Norton R, Horiuchi M, Pratt RE, Dzau VJ, MacMahon S. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet. 1995;345:1600-1603.
9. Bonnardeaux A, Davies E, Jeunemaitre X, Féry I, Charru A, Clauser E, Tiret L, Cambien F, Corvol P, Soubrier F. Angiotensin II type 1 receptor gene polymorphism in human essential hypertension. Hypertension. 1994;24:63-69.
10. Amant C, Hamon M, Bauters C, Richard F, Helbecque N, McFadden EP, Escudero X, Lablanche J-M, Amouyel P, Bertrand ME. The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction. J Am Coll Cardiol. 1997;29: 486-490.
11. Henrion D, Amant C, Benessiano J, Philip I, Plantefève G, Chatel D, Hwas U, Desmont JM, Durand G, Amouyel P, Lévy BI. Angiotensin II type 1 receptor gene polymorphism is associated with an increased vascular reactivity in the human mammary artery in vitro. J Vasc Res. 1998;35:356-362.
12. 1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy. Hypertension. 1998;32:825-830.
13. Buikema H, Pinto YM, van Geel PP, Rooks G, de Langen CDJ, de Graeff PA, van Gilst WH. Differential inhibition of plasma versus tissue ACE by Utibapril: biochemical and functional evidence for inhibition of vascular ACE activity. J Cardiovasc Pharmacol. 1997; 29:684-691.
14. 1166 variant of the angiotensin II type 1 receptor gene. Biochem Biophys Res Commun. 1995;213:725-729.
15. O'Malley JP, Maslen CL, Illingworth DR. Angiotensin-converting enzyme DD genotype and cardiovascular disease in heterozygous familial hypercholesterolemia. Circulation. 1998;97:1780-1783.
16. Ueda S, Elliott HL, Morton JJ, Connell JMC. Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension 1995;25:1266-1269.
17. Gunther S, Gimbrone MA Jr, Alexander RW. Regulation by angiotensin II of its receptors in resistance blood vessels. Nature. 1980; 287:230-232.
18. Poirier O, Georges J-L, Ricard S, Arveiler D, Ruidavets J-B, Luc G, Evans A, Cambien F, Tiret L. New polymorphisms of the angiotensin II type 1 receptor gene and their associations with myocardial infarction and blood pressure: the ECTIM study. J Hypertens. 1998; 16:1443-1447.
19. Morgan L, Crawshaw S, Baker PN, Edwards R, Broughton Pipkin F, Kalsheker N. Functional and genetic studies of the angiotensin II type 1 receptor in pre-eclamptic and normotensive pregnant women. J Hypertens. 1997;15:1389-1396.
20. Schmidt S, Beige J, Walla-Friedel M, Michel MC, Sharma AM, Ritz E. A polymorphism in the gene for the angiotensin II type 1 receptor is not associated with hypertension. J Hypertens. 1997;15:1385-1388.
21. Takami S, Katsuya T, Rakugi H, Sato N, Nakata Y, Kamitani A, Miki T, Higaki J, Ogihara T. Angiotensin II type 1 receptor gene polymorphism is associated with increase of left ventricular mass but not with hypertension. Am J Hypertens. 1998;11:316-321.
22. Liyou N, Davis D, James K, Simons L, Friedlander Y, Simons J, McCallum J, Johnson A. The A1166C mutation in the angiotensin II type 1 receptor and hypertension in the elderly. Clin Exp Pharmacol Physiol. 1999;26:525-526.
23. Gardemann A, Hguyen QD, Humme J, Stricker J, Katz N, Tillmans H, Herhlein FW, Rau M, Haberbosch W. Angiotensin II type 1 receptor A1166C gene polymorphism: absence of an association with the risk of coronary artery disease and myocardial infarction and of a synergistic effect with angiotensin-converting enzyme gene polymorphism on the risk of these diseases. Eur Heart J. 1998;19:1657-1665.
24. Jeunemaitre X, Ledru F, Battaglia S, Guillanneuf MT, Courbon D, Dumont C, Darmon O, Guize L, Guermonprez JL, Diebold B, Ducimetiere P. Genetic polymorphisms of the renin-angiotensin system and angiographic extent and severity of coronary artery disease: the CORGENE study. Hum Genet. 1997;99:66-73.